| Q36395133 | Age-Related Conjunctival Disease in the C57BL/6.NOD-Aec1Aec2 Mouse Model of Sjögren Syndrome Develops Independent of Lacrimal Dysfunction. |
| Q72137968 | Case of conjunctival disease due to silver nitrate deposits |
| Q79250911 | Clinical evaluation of measurement method for antigen specific IgE in tears of patients with allergic conjunctival disease |
| Q46958561 | Concentration of soluble interleukin-6 receptors in tears of allergic conjunctival disease patients |
| Q37091331 | Conjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma: a meta-analysis of randomised clinical trials |
| Q33222290 | Elevated levels of human alpha -defensin in tears of patients with allergic conjunctival disease complicated by corneal lesions: detection by SELDI ProteinChip system and quantification |
| Q62116773 | Evaluation of ocular surface inflammation in the presence of dry eye and allergic conjunctival disease |
| Q81416642 | Evaluation of total and allergen-specific secretory IgA in tears of allergic conjunctival disease patients |
| Q33651488 | Human oestriasis acquired in Florence and review on human myiasis in Italy |
| Q45793104 | Ocular amylosis |
| Q21260367 | On the ocular findings in ochronosis: a systematic review of literature |
| Q95353818 | Pemphigus vulgaris with severe eye involvement |
| Q92853901 | Topical Tacrolimus for Chronic Allergic Conjunctival Disease with and without Atopic Dermatitis |
| Q57127131 | Trends in conjunctivochalasis research from 1986 to 2017: A bibliometric analysis |
| Q42367341 | Update on conjunctival pathology |
| Q84358744 | [A quality of life questionnaire for Japanese allergic conjunctival disease] |
| Q80045183 | [Diagnosis and treatment of allergic conjunctival disease] |
| Q88094785 | [GUIDELINES FOR THE CLINICAL MANAGEMENT OF ALLERGIC CONJUNCTIVAL DISEASE THE POINT OF THE MANAGEMENT WITH USING CONVENTIONAL TOOL AND EYE DROPS] |
| Q85661834 | [Guidelines for the clinical management of allergic conjunctival disease (2nd edition): the point of the management with using eye drops] |
| Q82373756 | [Guidelines for the clinical management of allergic conjunctival disease (2nd edition)] |
| Q95413517 | [How to use Japanese allergic conjunctival disease quality-of-life questionnaire (JACQLQ)] |
| Q84873320 | [Mechanism of onset and treatment in allergic conjunctival disease: cedar pollinosis and vernal keratoconjunctivitis] |